Skip to Main Content

Paper Details

G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Biomed Pharmacother
10
2022
Author NameAffiliation
Antonio Pineda-LucenaCenter for Applied Medical Research (CIMA), University of Navarra
  • 1 - 1

Datasets

Release 1.2